Why the study?
Does age ≤ 40 years reduce 30-day mortality in patients with STEMI undergoing pPCI?
Population
1,055 consecutive patients with ST-segment elevation myocardial infarction undergoing primary percutaneous…
Comparison
Age ≤ 40 years vs Age > 40 years
Design
Cohort
Follow-up
30 days
Authors
Loading...
Young patients (≤ 40 years) presenting with STEMI and undergoing pPCI have distinct clinical and procedural characteristics with very low 30-day mortality compared to older patients.
Does age ≤ 40 years reduce 30-day mortality in patients with STEMI undergoing pPCI?
Young patients (≤ 40 years) presenting with STEMI and undergoing pPCI have distinct clinical and procedural characteristics with very low 30-day mortality compared to older patients.
Feijó et al. (2015) studied this question.